Healthcare real estate is the medical office building down the street, the outpatient surgery center off the highway, the dialysis clinic next to the hospital, the urgent-care storefront in a strip center. What ties them together is a tenant who treats patients on the premises and a lease structured around equipment, build-out, and a clinical practice that does not relocate on a whim. For an investor selling a property and racing a 1031 exchange clock, or placing proceeds in a Delaware Statutory Trust, healthcare offers a rent stream tied to demographics that only run one direction. This guide covers what the sector includes, why it tends to yield more than core net lease, who signs the leases, where the risks hide, and how most accredited investors buy it.
Key Takeaways
- Underwrite the tenant's credit and its payer mix as carefully as the real estate; reimbursement risk is specific to this sector.
- Specialization cuts both ways: it keeps tenants glued in place, but it makes a vacant medical building slow and costly to backfill.
- Diversified healthcare DSTs spread tenant, specialty, and policy risk across markets, which is much of why the pooled structure fits this sector.
What healthcare real estate covers
Healthcare is not one building type. It runs from the dressed-up office building full of physician practices to the highly specialized surgery suite that would be expensive to convert to anything else. The medical office building, or MOB, is the workhorse. It looks like a normal multi-tenant office on the outside and houses orthopedists, cardiologists, imaging, lab draw stations, and primary-care groups inside. Most healthcare DSTs are built around these.
Step up in specialization and you reach the outpatient and ambulatory surgery centers, where procedures that once meant a hospital admission now happen in a half-day. Dialysis clinics run a third or so of their patients several times a week, every week, for years, which makes their occupancy unusually sticky. Urgent care fills the gap between a primary-care appointment and an emergency room and has spread into retail-style locations. Around the edges sit imaging centers, rehab and physical therapy, and behavioral-health space.
The common thread is that the tenant has poured real money into the space. A surgery center or dialysis suite is not a place a tenant abandons casually, because the plumbing, power, and medical gas were engineered for that use and the licenses are tied to the address. That sunk cost is the quiet engine under this whole sector.
Why demand keeps climbing
The demand case is demographic, and it is unusually easy to see coming. The 65-and-over population in the United States is growing faster than any other age band, and older patients consume far more healthcare than younger ones. A person past 75 visits a doctor several times more often than someone in their thirties. None of that is a forecast; the people who will be 75 in ten years are already 65 today.
On top of the aging curve, care keeps migrating out of the hospital. Procedures move to lower-cost outpatient settings because insurers prefer it and patients prefer it, which pushes demand toward exactly the freestanding medical buildings that show up in DSTs. Imaging, surgery, infusion, dialysis: each shift out of the inpatient setting fills a building the trust can own.
We tell clients this is the part of the thesis that does not depend on the economy. People do not skip dialysis in a downturn, and the internet has not figured out how to perform a colonoscopy. Healthcare spending grows through recessions and is largely immune to the e-commerce pressure that has reshaped so much of retail. That resilience is a meaningful part of why the rent shows up.
Who signs the lease
The tenant roster is what separates a strong healthcare deal from a shaky one, and it is more varied than the net-lease world. At the top sit the health systems themselves: a regional hospital network leasing a medical office building it uses to keep referrals inside the family. A lease backed by a large nonprofit or investment-grade health system reads like a credit-tenant lease and prices accordingly.
Below the systems are the large specialty operators. National dialysis is dominated by a couple of public companies, DaVita and Fresenius among them, whose clinics anchor many of the dialysis deals on the market. Ambulatory surgery is increasingly run by public platforms and large physician groups. Urgent care has its own roster of regional and national brands. Then there are independent physician groups, strong local practices that may not carry a credit rating but have decades of patients and a build-out they cannot easily walk away from.
Reading which kind of tenant you have is the work. A health-system guarantee is one animal; a single-specialty practice with a personal guarantee is another, even if both pay rent reliably today. The build-out and the licensing keep both in place, but the balance sheet behind the lease is where an investor going it alone most often misjudges the risk.
Why healthcare tenants stay put
Tenant retention is the feature that makes healthcare different from a generic office building, and it comes down to money and patients. A specialty practice can spend hundreds of dollars per square foot finishing out a suite: lead-lined imaging rooms, surgical infrastructure, medical gas, reinforced floors, specialized HVAC. None of that travels. Moving means rebuilding it somewhere else and going dark during the transition, which a busy practice will avoid almost at any reasonable rent.
Patients are the second anchor. A practice builds its book around an address. Patients learn where to park, referring physicians learn where to send people, and the local reputation attaches to the location as much as the doctor. Pulling up stakes risks the patient base, not merely the build-out. The result is renewal behavior that net-lease retail can only envy: many medical tenants stay for two, three, or four lease terms in the same suite.
A surgeon does not move a surgery center to save two dollars a foot. The build-out and the patients hold the tenant in place, and that stickiness is most of the safety in the rent.
Gerald F. "Jerry" Baker, IIIOn-campus versus off-campus medical office
One distinction shapes a medical office deal more than almost anything else: whether the building sits on a hospital campus or away from it. The two are priced differently and carry different risks, and an investor should know which they are buying.
An on-campus building shares a parking lot or a connector with the hospital. Specialists want to be there because they round on inpatients and operate next door, so the leasing demand is durable and the hospital itself is often the landlord's best friend. The trade-off is that the building's fortunes are tied to that one hospital. Off-campus buildings, by contrast, sit where the patients live, in the suburbs and growing exurbs. They serve the outpatient shift directly and draw from a wider set of providers, but they lean on location and demographics rather than the gravity of a hospital next door.
Neither is automatically better. On-campus tends to lease with less drama and command a richer price; off-campus tends to yield a bit more and ride the outpatient growth story. The question for any specific deal is which set of tailwinds and which set of risks you are signing up for.
Yields, returns, and what the record shows
Healthcare is bought for income with a stronger growth tilt than core net lease, and the benchmark reflects it. Across the healthcare offerings we track in the current market, going-in yields run meaningfully higher than the low-5 percent range typical of plain net lease, which is one of the reasons the sector earns a look from yield-focused exchangers.
Realized results from healthcare programs that have run their full course round out the picture. The figures below come from 6 full-cycle healthcare deals in our sponsor track-record database. They reflect sponsor track records across the marketplace we monitor, not Baker 1031's own returns, and past performance does not guarantee future results. Six is a small sample, so read these as directional rather than predictive.
| Metric | Healthcare | Basis |
|---|---|---|
| Avg. going-in yield | 6.41% | Current market benchmark |
| Avg. yield, high end | 7.03% | Current market benchmark |
| Benchmark rent growth | 15.43% | Current market benchmark |
| Avg. annual return, realized | 8.5% | 6 full-cycle deals |
| Avg. equity multiple, realized | 1.68x | 6 full-cycle deals |
| Avg. hold, realized | 5.9 yrs | 6 full-cycle deals |
Benchmark yields from Baker 1031 sector data; realized figures from 6 full-cycle healthcare programs in the Baker 1031 sponsor track-record database. Small sample, illustrative, not a projection or guarantee.
That yield premium is not free money. Healthcare leases can carry tenant credit that is harder to read than a national pharmacy, and the buildings are more specialized and harder to backfill. The extra yield is partly compensation for that work. The benchmark rent-growth figure points to the other half of the story: scheduled escalations and the demand tailwind give healthcare a bit more upward drift than the flattest net-lease deals.
What changes inside a DST
Almost no accredited investor buys a single surgery center outright. They buy a fractional interest in a Delaware Statutory Trust that owns one building or a portfolio of them. The trust holds title, a professional sponsor runs it, and each investor owns a beneficial interest sized to whatever their exchange requires, down to the dollar. That sizing solves the same problem it solves everywhere: a 1031 exchange has to absorb a precise number, and you cannot buy 58 percent of a dialysis clinic, but you can buy 58 percent worth of a DST.
Pooling matters more in healthcare than in vanilla net lease, because the buildings are harder to backfill. A trust holding a dozen medical office buildings across several markets does not live or die with one practice closing. One vacancy trims the distribution; it does not end the deal. As a current example on our shelf, the AEI Healthcare Portfolio VII DST, sponsored by AEI Capital Corporation, is a healthcare DST presently available to accredited investors and illustrates the portfolio approach sponsors take in this sector.
The constraint is the same one that governs every DST. Under Revenue Procedure 2004-86, the trust operates inside tight guardrails sometimes called the "seven deadly sins." Once the offering closes, the sponsor cannot raise new equity, cannot refinance, and generally cannot sign new leases except in narrow circumstances such as a tenant bankruptcy. In a specialized sector where re-leasing a surgery suite takes real time, that lack of room to maneuver is exactly why sponsors gravitate to long leases backed by sticky, well-capitalized tenants.
Reimbursement and regulatory risk
Healthcare carries a risk that retail net lease does not: the tenant's revenue depends heavily on what government and private insurers pay. Medicare and Medicaid reimbursement rates set the economics for a large share of medical practices, and those rates change with policy. A cut to dialysis reimbursement or a shift in how surgery is paid for flows straight to the tenant's ability to make rent, even when the building and the demand are fine.
Regulation adds a second layer. Healthcare is among the most heavily licensed uses in commercial real estate. Certificates of need, accreditation, and state licensing tie a practice to its address and its approvals, which cuts both ways: it keeps tenants in place, but it also means a regulatory misstep can disrupt a tenant in a way a clothing retailer never faces.
We do not treat these as reasons to avoid the sector. We treat them as reasons to underwrite the tenant's payer mix and the durability of its reimbursement, not only the lease term. A diversified DST spread across specialties and geographies softens any single policy shock, which is part of why the pooled structure fits healthcare so well.
Where healthcare deals can go wrong
The calm demographic story hides specific risks. The first is backfill. A purpose-built surgery center or dialysis suite is expensive to convert to another use, so a departing tenant can leave a hole that takes far longer and more capital to fill than a plain retail box would. Specialization is the source of the sticky tenancy and the source of the re-leasing risk at the same time.
Credit risk sits alongside it. A long lease is only as good as the tenant honoring it, and physician-group or single-operator credit can be harder to read than a public retailer. Add the reimbursement and regulatory exposure above, the interest-rate sensitivity that all cap-rate-priced real estate carries, and, inside a DST, the illiquidity and the deliberate lack of investor control that come with the 1031 treatment. These are private placements sold only to accredited investors, and an early exit is rarely simple.
How these investments end
Healthcare DSTs do not run forever. The standard path is a sale: the sponsor markets the property near the end of the hold, sells it, and returns capital and any gain to investors, who can pay the tax or roll into a fresh 1031 exchange and keep deferring. Realized hold periods in the sector have tended to run shorter than the long net-lease holds, in part because demand for stabilized medical assets has been strong enough to sell into.
Some programs offer a second path through a 721 UPREIT exchange, in which a real estate investment trust acquires the property and investors receive operating-partnership units instead of cash. That can turn an illiquid, single-sector position into a stake in a larger diversified REIT, with its own tax and liquidity trade-offs worth reading closely before treating it as an upgrade. As with any DST, the debt usually has to be retired through the sale or rollover rather than refinanced in place, a direct consequence of the Revenue Procedure 2004-86 rules.
Who it suits, and who should look past it
Healthcare fits an investor who wants a higher current yield than core net lease and is comfortable underwriting a less familiar tenant to get it. Exchangers who like the demographic tailwind, retirees who want income with a bit more growth than the flattest pharmacy lease offers, and investors who want a recession- and e-commerce-resistant corner of real estate tend to be the natural buyers.
It is a weaker fit for someone who wants the simplest possible credit story or the deepest liquidity. The tenants take more work to read, the buildings are harder to backfill, and the reimbursement overlay is a real variable that a net-lease pharmacy does not carry. If you want the plainest credit-tenant rent check, classic net lease may sit easier. Healthcare asks for a little more diligence and pays a little more yield for the trouble. Knowing which trade you want is the first decision, and it is worth making before you start identifying replacement property.
Working with Baker 1031
Most investors reach diversified, institutional healthcare real estate through a Delaware Statutory Trust rather than chasing a single medical building, because it lowers the entry point, spreads tenant and specialty risk, and fits an exact exchange amount. We provide sponsor-agnostic diligence on healthcare DST programs, read the payer mix and the leases behind them, and we are paid to be skeptical on your behalf rather than to push any one sponsor's deal. Where a current healthcare offering fits, such as the AEI Healthcare Portfolio VII DST, we walk through the tenants and the structure in plain terms.
The 45-day identification window moves fast, so the time to know your options is before you sell, not after. We keep a current shelf of vetted healthcare and other DST offerings open to accredited investors, and we are happy to compare a healthcare deal against the rest of the market with you. View Available Healthcare DSTs to start the conversation.
View Available Healthcare DSTs →
Sources & References
- IRS. Like-Kind Exchanges — Real Estate Tax Tips
- U.S. SEC — Investor.gov. Investor Bulletin: Non-Traded REITs
